SGRY Stock Analysis: Buy, Sell, or Hold?
SGRY - Surgery Partners, Inc. Common Stock
$12.26
0.34 (2.85%)
▲
5d:
+1.74%
30d:
-11.93%
90d:
-21.66%
BUY
HIGH Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: May 11, 2026
Smart Money Accumulation
SGRY is down 5.8% this week, but smart money is accumulating calls. Top strike: $15 2026-05-15 with 30 OI. Call ratio: 100% View Scanner →
Strength: 7.9/10
Get Alerted When SGRY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: SGRY shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: SGRY shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$18.41
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$11.43
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 23.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SGRY is currently trading at $12.26, which is considered slightly low relative to its 30-day fair value range of $11.81 to $14.60. From a valuation perspective, the stock is trading at a premium (Forward PE: 30.6) compared to its historical average (23.6). At these levels, the market is pricing in 9.0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, SGRY is in a downtrend. The price is approaching resistance at $12.46. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $18.80 (+53.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SGRY is in a downtrend. The price is approaching resistance at $12.46. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $18.80 (+53.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$11.81 -
$14.60
Company Quality Score
60/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
78.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 53.3% below Wall St target ($18.80)
- NEUTRAL: Trading at premium valuation - market expects 9.0% growth which is achievable
Fair Price Analysis
30-Day Fair Range
$11.81 -
$14.60
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$11.41
Resistance Level
$12.46
Current Trend
Downtrend
Technical data as of
Apr 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
30.61
Wall Street Target
$18.80
(+53.3%)
Revenue Growth (YoY)
2.4%
Profit Margin
-2.4%
Valuation Premium vs History
+9.0% premium
PE vs Historical
30.6 vs 23.6
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+9.0%
(market-implied from PE analysis)
1-Year Target
$13.36
(+9%)
2-Year Target
$14.57
(+19%)
3-Year Target
$15.88
(+30%)
3-Yr Target (if PE normalizes)
(PE: 31→24)
PE COMPRESSION
$12.24
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 30.6, Growth: 98.4%)
$41.38
(+238%)
Base:
(SPY PE: 22.4, Growth: 98.4%)
$30.21
(+146%)
Bear:
(PE: 19.0, Growth: 98.4%)
$25.68
(+110%)
Share & Embed Analysis
Last updated: April 02, 2026 4:33 AM ET
Data refreshes hourly during market hours. Next update: 5:33 AM
Data refreshes hourly during market hours. Next update: 5:33 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SGRY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
12
Sells
Net
INSIDERS SELLING
Recent Transactions
David T Doherty
SELL
8867 shares
2026-03-16
Jason Eric Evans
SELL
20400 shares
2026-03-16
Danielle Burkhalter
SELL
3469 shares
2026-03-13
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$261 | 58 HOLD |
|
HCA
HCA Holdings Inc |
BUY
25 analysts |
$543 | 58 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$143 | 53 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$22 | 47 HOLD |
|
ASTH
Astrana Health Inc |
STRONG BUY
12 analysts |
$36 | 65 BUY |
Advanced SGRY Option Strategies
Professional options setups generated by AI based on today's SGRY price and gamma walls.
